Equities

Wockhardt Ltd

WOCKPHARMA:NSI

Wockhardt Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,168.30
  • Today's Change-34.70 / -2.88%
  • Shares traded125.02k
  • 1 Year change+312.83%
  • Beta1.9982
Data delayed at least 15 minutes, as of Nov 14 2024 04:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(4200)(6240)(4110)
Depreciation/depletion2,2302,5102,470
Non-Cash items4,5403,8503,070
Cash taxes paid, supplemental300110970
Cash interest paid, supplemental1,9702,4201,900
Changes in working capital(380)1,4102,700
Total cash from operations2,1901,5304,130
INVESTING
Capital expenditures(2160)(2090)(2120)
Other investing and cash flow items, total790840110
Total cash from investing(1370)(1250)(2010)
FINANCING
Financing cash flow items2,040(330)(1470)
Total cash dividends paid------
Issuance (retirement) of stock, net4,68007,480
Issuance (retirement) of debt, net(3380)(2820)(6720)
Total cash from financing3,340(3150)(710)
NET CHANGE IN CASH
Foreign exchange effects(10)70(30)
Net change in cash4,150(2800)1,380
Net cash-begin balance/reserved for future use9003,7002,320
Net cash-end balance/reserved for future use5,0509003,700
SUPPLEMENTAL INCOME
Depreciation, supplemental2,2302,5102,470
Cash interest paid, supplemental1,9702,4201,900
Cash taxes paid, supplemental300110970
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.